A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
Status:
Recruiting
Trial end date:
2027-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of guselkumab treatment compared
with placebo (an inactive substance with no medicine) in preventing recurrence of Crohn's
disease in participants after surgery.